Evidence map›Paper›PMID 21271346›Full record

Trial reportInternational journal of colorectal disease2011

Transanal endoscopic microsurgery for rectal cancer. Long-term oncologic results.

Jose M Ramirez, Vicente Aguilella, Javier Valencia, Javier Ortego, Jose A Gracia, Pilar Escudero, Ricardo Esco, Mariano Martinez

Abstract readClinical Trial
PubMed Publisher
In one paragraph

Trial report in International journal of colorectal disease, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Trial
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Observational
  11. Transanal Minimally Invasive Surgery.Clinics in colon and rectal surgery · 2017
    Review
  12. Article
  13. Review
  14. Transanal Endoscopic Microsurgery.Clinics in colon and rectal surgery · 2015
    Review
  15. Local excision by transanal endoscopic surgery.World journal of gastroenterology · 2015
    Review
  16. Outcomes of rectal cancer treatment--influence of age?International journal of colorectal disease · 2014
    Article
  17. Transanal endoscopic microsurgery: a review.Canadian journal of surgery. Journal canadien de chirurgie · 2014
    Review
  18. Article
  19. Article
  20. Practice patterns and long-term survival for early-stage rectal cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jose M RamirezDepartment of Colorectal Surgery, University Hospital, Zaragoza, Spain. jramirez@unizar.es
Vicente Aguilella
Javier Valencia
Javier Ortego
Jose A Gracia
Pilar Escudero
Ricardo Esco
Mariano Martinez

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeLocal excision of malignant rectal tumors remains controversial due to the lack of prospective studies. The principal aim of this paper is to analyze survival and recurrence of patients with rectal cancer who were operated by transanal endoscopic microsurgery with curative intention.

methodsIn 1997, we started a prospective protocol for patients who had T1/T2 rectal tumors: transanal local full-thickness excision was considered curative in T1 low risk (group A); patients with T1 high-risk and T2 low-risk tumors received postoperative radiotherapy (group B). From 1997 to 2006, 88 patients were enrolled. Sixty eight entered the study after the preoperative workup and 20 patients with an initial diagnosis of adenoma after postoperative definitive pathological assessment.

resultsAfter definitive histological findings, 54 patients were to group A, 28 to group B, and 6 had immediate radical surgery. One patient was lost for follow-up. At a mean follow-up of 71 months, 7 (4 from group A and 3 from group B) out of 81 patients recurred. Five-year overall survival was of 94% and cancer-specific survival of 96%.

conclusionsOur data support that transanal endoscopic microsurgery is an adequate treatment for T1 low-risk tumor, and no additional measures are required. For T2 low-risk lesions, our study showed a higher local recurrence rate than that reported after radical surgery but a similar survival outcome.

Indexed as

EndoscopyAdultAgedAged, 80 and overAnal CanalFemaleFollow-Up StudiesHumansMaleMicrosurgeryMiddle AgedNeoplasm Recurrence, LocalNeoplasm StagingPreoperative CareRectal NeoplasmsSurvival Analysis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.